Interpretation of Variants in Clinical Genomics

Author:

Jackson Maria,Stobo Daniel

Abstract

Abstract Many health conditions are genetic in origin, and it is often necessary to identify the causative DNA variant(s) in the patient in order to confirm a potential genetic diagnosis, so that optimal management and/or treatment can be implemented. This process can be complicated by the massive amount of variation present in all our genomes, so that distinguishing pathogenic variants from benign ones can be challenging. In order to provide consistency and improved validity of interpretations from different diagnostic laboratories across the world, professional guidelines have recently been published which specify how various types of evidence from scientific literature, databases, functional studies and in silico analysis should be combined to generate a classification for a variant. Ongoing work seeks to improve these guidelines, including the generation of versions specific for particular conditions and specific guidelines for classification of copy number variants and somatic variants. Key Concepts Analysis of patient DNA to identify pathogenic variants is often a critical step in confirming a genetic diagnosis. Most of the variants found in any human genome are benign, so clinical scientists need to be able to identify which are (likely) pathogenic. Other reports of a variant, in scientific literature or databases, and/or reports from functional assays can help to classify variants as (likely) benign or (likely) pathogenic. Computer software can be used to conduct in silico analysis to predict potential pathogenicity of a variant. Professional guidelines have been generated for combining different types of evidence during variant interpretation, and these are used internationally, to ensure consistent outcomes in variant interpretation, both in general use and for specific genetic conditions. Despite careful evaluation according to the guidelines, many variants identified in patient DNA remain as variants of uncertain significance (VUS) due to insufficient or contradictory evidence.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3